Connect your AI

Clorox CLX Equity Method Income

Discontinued — last reported Q4 '16

Equity Method Income at other companies

Church & DwightCHD

$2.3M+43.8%

Kimberly-ClarkKMB

$53M+20.5%

Keurig Dr PepperKDP

——

Segments

By segment

Health and Wellness$0—

Household$0—

International$0—

Lifestyle$0—

Other financials

Income statement

Revenue$1.7B+0.1%

Gross profit$722.0M-3.0%

Net income$187.0M+0.5%

EPS (diluted)$1.54+2.7%

Balance sheet

Cash & equivalents$1.2B+418%

Total debt$4.5B+52.4%

Total equity-$67.0M-348%

Total assets$6.4B+16.8%

Cash flow

Operating cash flow$311.0M+72.8%

CapEx$43.0M-18.9%

Free cash flow$269.0M+112%

Valuation

Market cap$11.58B-30.9%

Enterprise value$14.88B-24.1%

P/E15.3×-8.8×

P/S1.7×-0.7×

Profitability

Gross margin43.8%-1.4pp

Net margin11.2%+1.3pp

FCF margin11.5%+1.8pp

Returns & leverage

Return on equity249.6%+147pp

Debt / equity9.1×+0.1×

Current ratio0.8×+0.1×

Where this comes from

Reported directly by Clorox in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: Clorox’s 10-K, filed August 16, 2016, on SEC EDGAR. View the filing →